PubMed:10352279 / 1009-1289 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":280},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":280},"obj":"Sentence"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"jnlpba-st-training","denotations":[{"id":"T27","span":{"begin":45,"end":49},"obj":"cell_type"},{"id":"T28","span":{"begin":70,"end":74},"obj":"protein"},{"id":"T29","span":{"begin":89,"end":107},"obj":"cell_type"},{"id":"T30","span":{"begin":169,"end":175},"obj":"DNA"},{"id":"T31","span":{"begin":217,"end":230},"obj":"protein"},{"id":"T32","span":{"begin":234,"end":246},"obj":"protein"},{"id":"T33","span":{"begin":264,"end":268},"obj":"protein"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"GENIAcorpus","denotations":[{"id":"T29","span":{"begin":45,"end":49},"obj":"cell_type"},{"id":"T30","span":{"begin":51,"end":55},"obj":"other_name"},{"id":"T31","span":{"begin":70,"end":74},"obj":"protein_molecule"},{"id":"T32","span":{"begin":89,"end":92},"obj":"protein_molecule"},{"id":"T33","span":{"begin":103,"end":107},"obj":"cell_type"},{"id":"T34","span":{"begin":169,"end":175},"obj":"DNA_domain_or_region"},{"id":"T35","span":{"begin":185,"end":198},"obj":"other_name"},{"id":"T36","span":{"begin":217,"end":230},"obj":"protein_molecule"},{"id":"T37","span":{"begin":234,"end":246},"obj":"protein_molecule"},{"id":"T38","span":{"begin":264,"end":268},"obj":"protein_molecule"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"semrep-sample","denotations":[{"id":"E1-ab-8","span":{"begin":15,"end":41},"obj":"cui:C0162493"},{"id":"E2-ab-8","span":{"begin":51,"end":55},"obj":"cui:C0872343"},{"id":"E3-ab-8","span":{"begin":70,"end":74},"obj":"cui:C1332709"},{"id":"E4-ab-8","span":{"begin":89,"end":92},"obj":"cui:C1367475"},{"id":"E5-ab-8","span":{"begin":93,"end":102},"obj":"cui:C1515877"},{"id":"E6-ab-8","span":{"begin":113,"end":116},"obj":"cui:C1518422"},{"id":"E7-ab-8","span":{"begin":127,"end":136},"obj":"cui:C0205217"},{"id":"E8-ab-8","span":{"begin":154,"end":161},"obj":"cui:C1521761"},{"id":"E9-ab-8","span":{"begin":169,"end":175},"obj":"cui:C1332709"},{"id":"E10-ab-8","span":{"begin":169,"end":175},"obj":"cui:C0600508"},{"id":"E11-ab-8","span":{"begin":185,"end":198},"obj":"cui:C0949466"},{"id":"E12-ab-8","span":{"begin":206,"end":213},"obj":"cui:C0392747"},{"id":"E13-ab-8","span":{"begin":247,"end":253},"obj":"cui:C0441889"},{"id":"E14-ab-8","span":{"begin":264,"end":268},"obj":"cui:C1332709"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S9","span":{"begin":0,"end":280},"obj":"Sentence"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"genia-medco-coref","denotations":[{"id":"C13","span":{"begin":89,"end":107},"obj":"NP"},{"id":"C14","span":{"begin":165,"end":175},"obj":"NP"},{"id":"C15","span":{"begin":264,"end":279},"obj":"NP"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}

{"project":"metamap-sample","denotations":[{"id":"T16","span":{"begin":128,"end":137},"obj":"C0205217"},{"id":"T29","span":{"begin":94,"end":103},"obj":"C1879547"},{"id":"T35","span":{"begin":170,"end":176},"obj":"C0600508"},{"id":"T39","span":{"begin":16,"end":42},"obj":"C0162493"},{"id":"T43","span":{"begin":186,"end":199},"obj":"C0949466"},{"id":"T45","span":{"begin":52,"end":56},"obj":"C0949632"},{"id":"T49","span":{"begin":90,"end":93},"obj":"C1367475"},{"id":"T60","span":{"begin":118,"end":124},"obj":"C2825142"},{"id":"T75","span":{"begin":200,"end":206},"obj":"C0442726"},{"id":"T77","span":{"begin":255,"end":264},"obj":"C0332282"},{"id":"T78","span":{"begin":114,"end":117},"obj":"C1518422"},{"id":"T79","span":{"begin":46,"end":50},"obj":"C1321301"},{"id":"T81","span":{"begin":57,"end":65},"obj":"C0443289"},{"id":"T96","span":{"begin":207,"end":214},"obj":"C0443172"},{"id":"T100","span":{"begin":138,"end":145},"obj":"C1167622"},{"id":"T103","span":{"begin":149,"end":154},"obj":"C2826298"},{"id":"T107","span":{"begin":155,"end":162},"obj":"C1521761"},{"id":"T110","span":{"begin":218,"end":219},"obj":"C0221138"}],"text":"In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation."}